Article Versions Notes

Ho H-Y, Chen Y-H, Lo C-J, Tang H-Y, Chang S-W, Fan C-M, Ho Y-H, Lin G, Chiu C-Y, Lin C-M, et al. Combined Plasma DHA-Containing Phosphatidylcholine PCaa C38:6 and Tetradecanoyl-Carnitine as an Early Biomarker for Assessing the Mortality Risk among Sarcopenic Patients. Nutrients. 2024; 16(5):611. https://doi.org/10.3390/nu16050611

Ho, Hung-Yao, Yuan-Ho Chen, Chi-Jen Lo, Hsiang-Yu Tang, Su-Wei Chang, Chun-Ming Fan, Yu-Hsuan Ho, Gigin Lin, Chih-Yung Chiu, Chih-Ming Lin, and et al. 2024. "Combined Plasma DHA-Containing Phosphatidylcholine PCaa C38:6 and Tetradecanoyl-Carnitine as an Early Biomarker for Assessing the Mortality Risk among Sarcopenic Patients" Nutrients 16, no. 5: 611. https://doi.org/10.3390/nu16050611

Ho, H. -Y., Chen, Y. -H., Lo, C. -J., Tang, H. -Y., Chang, S. -W., Fan, C. -M., Ho, Y. -H., Lin, G., Chiu, C. -Y., Lin, C. -M., & Cheng, M. -L. (2024). Combined Plasma DHA-Containing Phosphatidylcholine PCaa C38:6 and Tetradecanoyl-Carnitine as an Early Biomarker for Assessing the Mortality Risk among Sarcopenic Patients. Nutrients, 16(5), 611. https://doi.org/10.3390/nu16050611